Mineralys Therapeutics Inc (MLYS)
SG&A Expense Growth
17.58%
Quarterly · Period ending:
MLYS SG&A Expense Growth
Latest reported17.58%period ending
Latest reported17.58%period ending
MLYS Quarterly SG&A Growth (QoQ) (0.00% → 17.58%)
Latest values, visible window
High-resolution chart · PNG
MLYS sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 17.5828% | |
| 51.1385% | |
| 43.353% | |
| 14.3245% | |
| 28.9281% | |
| -8.7524% | |
| 17.5952% | |
| 3.8338% | |
| 28.1522% | |
| 14.2573% | |
| 6.6773% | |
| -1.9995% | |
| 45.5955% | |
| 20.7763% | |
| 60.5572% | |
| 54.2986% | |
| 11.7573% | |
| 69.379% | |
| 0% |